Literature DB >> 9276860

Antiarrhythmic agents: current status and perspectives.

P Mátyus1, A Varró, J G Papp, H Wamhoff, I Varga, L Virág.   

Abstract

Mesh：

Substances：

Year:  1997        PMID： 9276860     DOI： 10.1002/(sici)1098-1128(199709)17:5<427::aid-med1>3.0.co;2-w

Source DB:  PubMed          Journal:  Med Res Rev        ISSN： 0198-6325            Impact factor:   12.944


× No keyword cloud information.
  5 in total

1.  QSAR studies on a number of pyrrolidin-2-one antiarrhythmic arylpiperazinyls.

Authors:  Alicja Nowaczyk; Katarzyna Kulig
Journal:  Med Chem Res       Date:  2011-01-07       Impact factor: 1.965

Review 2.  Potentially significant drug interactions of class III antiarrhythmic drugs.

Authors:  Weeranuj Yamreudeewong; Michael DeBisschop; Linda G Martin; Dennis L Lower
Journal:  Drug Saf       Date:  2003       Impact factor: 5.606

3.  Electromechanical and atrial and ventricular antiarrhythmic actions of CIJ-3-2F, a novel benzyl-furoquinoline vasodilator in rat heart.

Authors:  Gwo-Jyh Chang; Yung-Hsin Yeh; Tsung-Pin Lin; Chi-Jen Chang; Wei-Jan Chen
Journal:  Br J Pharmacol       Date:  2014-08       Impact factor: 8.739

4.  Cardiac electrophysiologic and antiarrhythmic actions of a pavine alkaloid derivative, O-methyl-neocaryachine, in rat heart.

Authors:  Gwo-Jyh Chang; Ming-Jai Su; Li-Man Hung; Shoei-Sheng Lee
Journal:  Br J Pharmacol       Date:  2002-06       Impact factor: 8.739

5.  Antiarrhythmic and antioxidant activity of novel pyrrolidin-2-one derivatives with adrenolytic properties.

Authors:  Jacek Sapa; Alicja Nowaczyk; Katarzyna Kulig
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2010-10-15       Impact factor: 3.000
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.